Morphine Adverse Reaction
7
0
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
29%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis
Intrathecal Dexamethasone and Atropine on Morphine Induced Post-operative Nausea and Vomiting on Caesarean Section
Intravenous Lignocaine Infusion in Laparoscopic Donor Nephrectomy
Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration
Two Dose Epidural Morphine for Post-cesarean Analgesia
Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron
Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section